USE OF SYNTHESIS INHIBITORS IN DEFINING A ROLE FOR BIOGENIC-AMINES DURING IMIPRAMINE TREATMENT IN DEPRESSED-PATIENTS
- 1 January 1975
- journal article
- research article
- Vol. 1 (2) , 239-249
Abstract
Endogenously depressed patients who showed an antidepressant response to the tricyclic drug imipramine continued to show sustained well being after .alpha.-MPT [.alpha.-methyl-p-tyrosine] was added whereas depression returned when small doses of PCPA [p-chlorophenylalanine] were added for brief periods. In 1 patient the antidepressant response to imipramine occurred after pre- and continued treatment with .alpha.-MPT. Urinary excretion levels of MHPG [3-methoxy-4-hydroxyphenylglycol] in 1 of the patients studied longitudinally did not correspond to the direction of clinical affective state but did reflect anticipated changes during .alpha.-MPT treatment. Serotonergic mechanisms are probably involved in the antidepressant effects of imipramine in man.This publication has 4 references indexed in Scilit:
- 3-Methoxy-4-Hydroxy Phenylglycol (MHPG) Excretion in Depressive StatesArchives of General Psychiatry, 1968
- Biochemical and pharmacologic effects of α-methyltyrosine in manJournal of Clinical Investigation, 1968
- Determination of urinary 3-methoxy-4-hydroxyphenyl-ethylene glycol by gas-liquid chromatography and electron capture detectionClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- Clinical‐pharmacological evaluation of p‐chlorophenylalanine: A new serotonin‐depleting agentClinical Pharmacology & Therapeutics, 1966